Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccine

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Rong, Yefei ^a   Jin, Dayong ^a   Wu, Wenchuan ^a   Lou, Wenhui ^a   Wang, Danshong ^a   Kuang, Tiantao ^a   Ni, Xiaoling ^a   Qin, Xinyu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CANCER VACCINE; DNA VACCINE; MUCIN 1; MUCIN 1 ANTIBODY; MUCIN 1 DNA VACCINE; PLASMID DNA; UNCLASSIFIED DRUG; CANCER ANTIBODY; MUC1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; C57BL 6 MOUSE; CANCER IMMUNIZATION; CANCER PREVENTION; CANCER SURVIVAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; FEMALE; GENE INSERTION; IMMUNE RESPONSE; MOLECULAR CLONING; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS CANCER; SURVIVAL TIME; TUMOR IMMUNITY; TUMOR VOLUME; VARIABLE NUMBER OF TANDEM REPEAT; ADENOCARCINOMA; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; C57BL MOUSE; GENETICS; IMMUNOLOGY; PANCREAS TUMOR; RANDOMIZATION; TANDEM REPEAT; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, NEOPLASM; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; CANCER VACCINES; CELL LINE, TUMOR; FEMALE; MICE; MICE, INBRED C57BL; MUCIN-1; PANCREATIC NEOPLASMS; RANDOM ALLOCATION; T-LYMPHOCYTES, CYTOTOXIC; TANDEM REPEAT SEQUENCES; VACCINES, DNA;

EID: 67650092642     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-191     Document Type: Article

References (25)

1. Jemal A Murray T Ward E Samuels A Tiwari RC Ghafoor A Feuer EJ Thun MJ Cancer statistics CA Cancer J Clin 2005, 55(1):10-30. 10.3322/ canjclin.55.1.10 15661684
2. Li D Xie K Wolff R Abbruzzese JL Pancreatic cancer The Lancet 2004, 363(9414):1049-1057. 10.1016/S0140-6736(04)15841-8
3. Ho SB Niehans GA Lyftogt C Yan PS Cherwitz DL Gum ET Dahiya R Kim YS Heterogeneity of mucin gene expression in normal and neoplastic tissues Cancer Res 1993, 53(3):641-651. 7678777
4. Peat N Gendler SJ Lalani N Duhig T Taylor-Papadimitriou J Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice Cancer Res 1992, 52(7):1954-1960. 1372533
5. Gendler SJ Spicer AP Lalani EN Duhig T Peat N Burchell J Pemberton L Boshell M Taylor-Papadimitriou J Structure and biology of a carcinoma-associated mucin, MUC1 Am Rev Respir Dis 1991, 144(3pt2):S42-47. 1892326
6. Nuti M Rughetti A Turchi V Apollonj-Ghetti C Scambia G Frati L Human B cell immune response to selected epitopes of the polymorphic epithelial mucin (PEM) in cancer patients In Vivo 1993, 7(6B):645-647. 7514896
7. Kotera Y Fontenot JD Pecher G Metzgar RS Finn OJ Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients Cancer Res 1994, 54(11):2856-2860. 7514493
8. von Mensdorff-Pouilly S Verstraeten AA Kenemans P Snijdewint FG Kok A Van Kamp GJ Paul MA Van Diest PJ Meijer S Hilgers J Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin J Clin Oncol 2000, 18(3):574-583. 10653872
9. Agrawal B Reddish MA Krantz MJ Longenecker BM Does pregnancy immunize against breast cancer? Cancer Res 1995, 55(11):2257-2261. 7538899
10. Apostolopoulos V Pietersz GA McKenzie IF Cell-mediated immune responses to MUC1 fusion protein coupled to mannan Vaccine 1996, 14(9):930-938. 10.1016/0264-410X(95)00258-3 8843637
11. Zhang S Graeber LA Helling F Ragupathi G Adluri S Lloyd KO Livingston PO Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice Cancer Res 1996, 56(14):3315-3319. 8764127
12. Lees CJ Apostolopoulos V Acres B Ong CS Popovski V McKenzie IF The effect of T1 and T2 cytokines on the cytotoxic T cell response to mannan-MUC1 Cancer Immunol Immunother 2000, 48(11):644-652. 10.1007/ s002620050013 10663612
13. Gong J Chen L Chen D Kashiwaba M Manome Y Tanaka T Kufe D Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells Gene Ther 1997, 4(10):1023-1028. 10.1038/sj.gt.3300496 9415307
14. Gilewski T Adluri S Ragupathi G Zhang S Yao TJ Panageas K Moynahan M Houghton A Norton L Livingston PO Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21 Clin Cancer Res 2000, 6(5):1693-1701. 10815887
15. Brossart P Wirths S Stuhler G Reichardt VL Kanz L Brugger W Induction of cytotoxic T lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells Blood 2000, 96(9):3102-3108. 11049990
16. Wu WC Jin DY Qin XY Lou WH Wang DS Ni XL Wu ZH The construction and cell transfection assay of MUC1-VNTR DNA vaccine for pancreatic cancer Chinese Journal of Experimental Surgery 2005, 22(9):1081-1083.
17. Jerome KR Bu D Finn OJ Expression of Tumor-associated Epitopes on Epstein-Barr Virus-immortalized B-Cells and Burkitt's Lymphomas Transfected with Epithelial Mucin Complementary DNA Cancer Res 1992, 52(21):5985-5990. 1382849
18. Corbett TH Roberts BJ Leopold WR Peckham JC Wilkoff LJ Griswold DP Jr Schabel FM Jr Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice Cancer Res 1984, 44(2):717-726. 6692374
19. Tang DC DeVit M Johnston SA Genetic immunization is a simple method for eliciting an immune response Nature 1992, 356(6365):152-154. 10.1038/ 356152a0 1545867
20. Sanjay G Dennis MK Robert AS DNA vaccines: Immunology, application, and optimization Annual review of immunology 2000, 18:927-973. 10.1146/ annurev.immunol.18.1.927 10837079
21. Tempero RM Rowse GJ Gendler SJ Hollingsworth MA Passively transferred anti-MUC1 antibodies cause neither autoimmune disorders nor immunity against transplanted tumors in MUC1 transgenic mice Int J Cancer 1999, 80(4):595-599. 10.1002/ (siAi)1097-0215(19990209)80:4<595::aid-ijc18>3.0.co;2-b 9935162
22. Snyder LA Goletz TJ Gunn GR Shi FF Harris MC Cochlin K McCauley C McCarthy SG Branigan PJ Knight DM A MUC1/IL-18 DNA vaccine induces anti-tumor immunity and increased survival in MUC1 transgenic mice Vaccine 2006, 24(16):3340-3352. 10.1016/j.vaccine.2006.01.014 16472547
23. Shi FF Gunn GR Snyder LA Goletz TJ Intradermal vaccination of MUC1 transgenic mice with MUC1/IL-18 plasmid DNA suppresses experimental pulmonary metastases Vaccine 2007, 25(17):3338-3346. 10.1016/ j.vaccine.2007.01.007 17292519
24. Pecher G Häring A Kaiser L Thiel E Mucin gene (MUC1) transfected dendritic cells as vaccine: Results of a phase I/II clinical trial Cancer Immunol Immunother 2002, 51(11-12):669-673. 10.1007/ s00262-002-0317-z 12439613
25. Ramanathan RK Lee KM McKolanis J Hitbold E Schraut W Moser AJ Warnick E Whiteside T Osborne J Kim H et al Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer Cancer Immunol Immunother 2005, 54(3):254-264. 10.1007/s00262-004-0581-1 15372205